Solifenacin Succinate 5 Mg (Page 5 of 6)

16 HOW SUPPLIED/STORAGE AND HANDLING

Solifenacin succinate tablets are available in bottles as:

Each 5 mg tablet is Yellow colored, round, biconvex, film coated tablet with ’44’ debossed on one side and V on the other side.

Bottle of 30 NDC 64380-941-04

Bottle of 90 NDC 64380-941-05

Each 10 mg tablet is Pink colored, round, biconvex, film coated tablet with ’45’ debossed on one side and V on the other side.

Bottle of 30 NDC 64380-942-04

Bottle of 90 NDC 64380-942-05

Store at 25°C (77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information).

Angioedema and Anaphylactic Reactions

Inform patients that angioedema and anaphylactic reactions have been reported in patients treated with solifenacin succinate. Angioedema and anaphylactic reactions may be life-threatening. Advise patients to promptly discontinue solifenacin succinate therapy and seek immediate attention if they experience edema of the tongue or laryngopharynx, or difficulty breathing [see Contraindications (4) and Warnings and Precautions (5.1)].

Urinary Retention

Inform patients that solifenacin succinate may cause urinary retention in patients with conditions associated with bladder outlet obstruction [see Warnings and Precautions (5.2)].

Gastrointestinal Disorders

Inform patients that solifenacin succinate may cause further decrease in gastrointestinal motility in patients with conditions associated with decreased gastrointestinal motility. solifenacin succinate has been associated with constipation and dry mouth. Advise patients to contact their health care providers if they experience severe abdominal pain or become constipated for 3 or more days [see Warnings and Precautions (5.3)].

Central Nervous System Effects

Because solifenacin succinate, like other antimuscarinic agents, may cause central nervous system effects or blurred vision, advise patients to exercise caution in decisions to engage in potentially dangerous activities until the drug’s effect on the patient has been determined [see Warnings and Precautions (5.4)].

Narrow-Angle Glaucoma

Inform patients that solifenacin succinate, like other antimuscarinics, may cause worsening of the glaucoma condition in patients with narrow-angle glaucoma [see Warnings and Precautions (5.5)].

Dry Skin

Inform patients that solifenacin succinate, like other antimuscarinics, may cause dry skin due to decreased sweating. Heat prostration due to decreased sweating can occur when solifenacin succinate is used in a hot environment [see Adverse Reactions (6.2)].

Distributed by:

Strides Pharma Inc.

East Brunswick, NJ 08816

07/2020

Patient Information

Solifenacin Succinate (soe” li fen’ a sin sux’ i nate)

Tablet

Read the Patient Information that comes with solifenacin succinate tablets before you start taking it and each time you get a refill. There may be new information. This leaflet does not take the place of talking with your doctor about your medical condition or treatment.

What are solifenacin succinate tablets?

Solifenacin succinate tablets are a prescription medicine for adults used to treat the following symptoms due to a condition called overactive bladder:

• Urge urinary incontinence: a strong need to urinate with leaking or wetting accidents

• Urgency: a strong need to urinate right away

• Frequency: urinating often.

Solifenacin succinate, 5 mg and 10 mg tablets are not approved for use in children.

Who should not take solifenacin succinate tablets?

Do not take solifenacin succinate tablets if you:

• are not able to empty your bladder (urinary retention)

• have delayed or slow emptying of your stomach (gastric retention)

• have an eye problem called “uncontrolled narrow-angle glaucoma”

• are allergic to solifenacin succinate or any of the ingredients in solifenacin succinate tablets. See the end of this leaflet for a complete list of ingredients.

What should I tell my doctor before taking solifenacin succinate tablets?

Before you take solifenacin succinate tablets, tell your doctor if you:

• have any stomach or intestinal problems or problems with constipation

• have trouble emptying your bladder or you have a weak urine stream

• have an eye problem called “narrow angle glaucoma”

• have liver problems

• have kidney problems

• have a rare heart problem called “QT prolongation”

• are pregnant or plan to become pregnant. It is not known if solifenacin succinate tablets will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant

• are breastfeeding or plan to breastfeed. It is not known if solifenacin succinate tablet passes into your breast milk. You and your doctor should decide if you will take solifenacin succinate tablets or breastfeed.

Tell your doctor about all the medicines you take , including prescription and nonprescription medicines, vitamins, and herbal supplements. Solifenacin succinate tablets may affect the way other medicines work, and other medicines may affect how solifenacin succinate tablets works.

How should I take solifenacin succinate tablets?

• Take solifenacin succinate tablets exactly as your doctor tells you to take it

• You should take 1 solifenacin succinate tablet 1 time a day

• You should take solifenacin succinate tablets with water and swallow the tablet whole

• You can take solifenacin succinate tablets with or without food

• If you miss a dose of solifenacin succinate tablets, begin taking solifenacin succinate tablets again the next day. Do not take 2 doses of solifenacin succinate tablets the same day

• If you take too much solifenacin succinate tablets, call your doctor or go to the nearest hospital emergency room right away.

What should I avoid while taking solifenacin succinate tablets?

Solifenacin succinate tablets can cause blurred vision or drowsiness. Do not drive or operate heavy machinery until you know how solifenacin succinate tablets affects you.

What are the possible side effects of solifenacin succinate tablets?

Solifenacin succinate tablets may cause serious side effects including:

Serious allergic reaction. Stop taking solifenacin succinate tablets and get medical help right away if you have:

o hives, skin rash or swelling

o severe itching

o swelling of your face, mouth or tongue

o trouble breathing

The most common side effects of solifenacin succinate tablets include:

• dry mouth

• constipation. Call your doctor if you get severe stomach area (abdominal) pain or become constipated for 3 or more days

• urinary tract infection

• blurred vision

Other side effects have been observed with anticholinergic drugs such as solifenacin succinate tablets and may include:

dry skin due to decreased sweating. Heat exhaustion or heat stroke can happen due to decreased sweating when solifenacin succinate tablets are used in hot environments. Symptoms may include:

o decreased sweating

o dizziness

o tiredness

o nausea

o increase in body temperature

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of solifenacin succinate tablets. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects.

You may report side effects to the FDA at 1-800-FDA-1088.

How should I store solifenacin succinate tablets?

• Store solifenacin succinate tablets between 59°F to 86°F (15°C to 30°C). Keep the bottle closed

• Safely throw away medicine that is out of date or no longer needed.

Keep solifenacin succinate tablets and all medicines out of the reach of children.

General information about the safe and effective use of solifenacin succinate tablets.

Medicines are sometimes prescribed for purposes other than those listed in Patient Information leaflets. Do not use solifenacin succinate tablets for a condition for which it was not prescribed. Do not give solifenacin succinate tablets to other people, even if they have the same symptoms you have. It may harm them.

This leaflet summarizes the most important information about solifenacin succinate tablets. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about solifenacin succinate tablets that is written for health professionals.

What are the ingredients in solifenacin succinate tablets?

Active ingredient: solifenacin succinate

Inactive ingredients: Colloidal Silicon dioxide (Aerosil 200) NF, Corn Starch NF (Maize Starch B-Pharma Grade), HPMC 2910/ Hypromellose USP, Hydroxy Propyl Methyl Cellulose USP (Methocel E5 Premium LV), Lactose Monohydrate NF – Pharmatose 200 M (Milled), Lactose Monohydrate NF (Super Tab 11SD), Macrogol/PEG NF, Magnesium Stearate NF (Ligamed MF-2-V), Talc USP, Titanium dioxide USP, Iron Oxide Yellow NF (for 5 mg solifenacin succinate tablet), and Iron Oxide Red NF (for 10 mg solifenacin succinate tablet).

What is overactive bladder?

Overactive bladder occurs when you cannot control your bladder contractions. When these muscle contractions happen too often or cannot be controlled you can get symptoms of overactive bladder, which are urinary frequency, urinary urgency, and urinary incontinence (leakage).

Distributed by:

Strides Pharma Inc.,

East Brunswick, NJ 08816

Revision: 07/2020

This Patient Information has been approved by the U.S. Food and Drug Administration.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.